Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dong-A Pharmaceutical Co., Ltd. Appoints New Co-CEO


Sunday, 3 Mar 2013 09:21pm EST 

Dong-A Pharmaceutical Co., Ltd. announced that it has appointed Lee Dong Hun as its new Co-Chief Executive Officer (Co-CEO), replacing Kim Won Bae, effective March 4, 2013. The current Co-CEO, Kang Jeong Seok, continues his duty as Co-CEO at the Company. 

Company Quote

127500.0
-1500.0 -1.16%
11:22pm EDT